Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer

Dirk O. Bauerschlag, Nicolai Maass, Peter Leonhardt, Frederik A. Verburg, Ulrich Pecks, Felix Zeppernick, Agnieszka Morgenroth, Felix M. Mottaghy, Rene Tolba, Ivo Meinhold-Heerlein, Karen Braeutigam

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageEnglish
JournalJournal of Translational Medicine
Volume13
DOIs
Publication statusPublished - 7 May 2015

Keywords

  • Ovarian cancer
  • FASN
  • FASN inhibitor
  • Cerulenin
  • Biomolecular marker
  • Cisplatin
  • Resistance
  • Chemotherapy
  • F-18-fluoromethylcholine
  • Imaging

Cite this

Bauerschlag, D. O., Maass, N., Leonhardt, P., Verburg, F. A., Pecks, U., Zeppernick, F., Morgenroth, A., Mottaghy, F. M., Tolba, R., Meinhold-Heerlein, I., & Braeutigam, K. (2015). Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer. Journal of Translational Medicine, 13. https://doi.org/10.1186/s12967-015-0511-3